1. Home
  2. BVS vs CBLL Comparison

BVS vs CBLL Comparison

Compare BVS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$9.50

Market Cap

716.8M

Sector

Health Care

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$18.61

Market Cap

750.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
CBLL
Founded
2011
2014
Country
United States
United States
Employees
N/A
280
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
716.8M
750.1M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
BVS
CBLL
Price
$9.50
$18.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$14.00
$23.20
AVG Volume (30 Days)
653.3K
262.3K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
163.46
N/A
EPS
0.04
N/A
Revenue
$568,087,000.00
N/A
Revenue This Year
$7.52
$29.57
Revenue Next Year
$7.06
$28.44
P/E Ratio
$232.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.81
$10.85
52 Week High
$11.25
$24.33

Technical Indicators

Market Signals
Indicator
BVS
CBLL
Relative Strength Index (RSI) 56.20 51.54
Support Level $8.43 $17.11
Resistance Level $11.00 $19.56
Average True Range (ATR) 0.37 0.83
MACD 0.11 0.07
Stochastic Oscillator 79.41 61.21

Price Performance

Historical Comparison
BVS
CBLL

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: